About Retro Bio
Retro Bio is a company based in San Francisco (United States) founded in 2020 by Sheng Ding, Matt Buckley, and Joe Betts Lacroix. It operates as a HealthTech. Retro Bio has raised $180 million across 1 funding round from investors including Sam Altman. The company has 21 employees as of December 31, 2022. Retro Bio offers products and services including Aging Therapies. Retro Bio operates in a competitive market with competitors including AMN Healthcare, Cross Country Healthcare, Medical Solutions, Toothio and Aya Healthcare, among others.
- Headquarter San Francisco, United States
- Employees 21 as on 31 Dec, 2022
- Founders Sheng Ding, Matt Buckley, Joe Betts Lacroix
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$9.53 K (USD)34as on Dec 31, 2022
-
Net Profit
-$4.49 K (USD)-230as on Dec 31, 2022
-
EBITDA
Not available
-
Total Equity Funding
$180 M (USD)
in 1 rounds
-
Latest Funding Round
$180 M (USD), Series D
Apr 06, 2022
-
Investors
-
Employee Count
21
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Retro Bio
Retro Bio offers a comprehensive portfolio of products and services, including Aging Therapies.
Therapies are developed to reverse age-related diseases effectively.
People of Retro Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Retro Bio
Retro Bio has successfully raised a total of $180M through 1 strategic funding round. The most recent funding activity was a Series D round of $180 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Retro Bio
Retro Bio has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Sam Altman.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SA
Sam Altman |
-
|
Locked | Locked | Locked |
Investor details for Retro Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Retro Bio
Investment portfolio details for Retro Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Retro Bio
Detailed financials for Retro Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Retro Bio Comparisons
Peer comparison for Retro Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Retro Bio
Retro Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AMN Healthcare, Cross Country Healthcare, Medical Solutions, Toothio and Aya Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AMN Healthcare is recognized as a leading healthcare staffing provider.
|
|
| Locked | Locked | Locked |
Healthcare staffing and workforce solutions are delivered nationwide.
|
|
| Locked | Locked | Locked |
Travel nursing jobs are offered to certified nurses nationwide.
|
|
| Locked | Locked | Locked |
Provider of dental staffing services
|
|
| Locked | Locked | Locked |
Provides medical staffing services to healthcare facilities.
|
|
| Locked | Locked | Locked |
Provider of clinical trial tooling & staffing services for physicians
|
Detailed competitors of Retro Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Retro Bio
Complete news archive for Retro Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Retro Bio
Retro Bio was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Retro Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Joe Betts Lacroix is the current CEO of Retro Bio. They have also founded this company.
Retro Bio is a funded company, having raised a total of $180M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Retro Bio is 21.
Annual revenue of Retro Bio is $9.53K as on Dec 31, 2022.
Retro Bio is focused on developing therapies that target aging mechanisms to increase healthy human lifespan. Age-related diseases are addressed at their source using advanced technologies like single-cell multi-omics and targeted delivery systems. Interventions are designed based on robust proofs of concept in mammals, with a feasible path to human clinical translation. The company operates as a generational pharma entity, structured as a portfolio of bets, emphasizing speed, vertical integration, and a culture of kindness and rigor within the biotechnology sector.
Retro Bio's top competitors include AMN Healthcare, Medical Solutions and Health Carousel.
Retro Bio offers Aging Therapies.
Retro Bio has 1 investor. Key investors include Sam Altman.